Loading…
Loading…
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
27 Aug 2026, 3:00 pmDue tomorrow
rd 150
9718205
GEM/2026/B/7884550
Two Packet Bid
BCG intavesical 40 mg per vial inj,leuprolide acetate 11 point 25 mg inj PFS,bethamechol 25 mg tab,
Udhampur, Jammu And Kashmir
Item wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
₹1 L
₹3 L
30%
Exempted
Yes
6 Aug 2026
6 Aug 2026
27 Aug 2026
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | BCG intavesical 40 mg per vial inj | as per specification | 150 | vial | UDHAMPUR | 30 |
| 2 | leuprolide acetate 11 point 25 mg inj PFS | as per specification | 20 | PFS | UDHAMPUR | 30 |
| 3 | bethamechol 25 mg tab | as per specification | 600 | No | UDHAMPUR | 30 |
| 4 | Desmopressin 0 point 1 mg tab | as per specification | 600 | No | UDHAMPUR | 30 |
| 5 | Solifenacin 10 mg tab | as per specification | 500 | No | UDHAMPUR | 30 |
| 6 | Mirabegron 25 mg tab | as per specification | 3,150 | No | UDHAMPUR | 30 |
| 7 | Mirabegron 50 mg tab | as per specification | 810 | No | UDHAMPUR | 30 |
| 8 | Darifenacin 7 point 5 mg tab | as per specification | 490 | No | UDHAMPUR | 30 |
| 9 | Alfuzosin 10 mg tab | as per specification | 2,700 | No | UDHAMPUR | 30 |
| 10 | Silodosiin 4 mg tab | as per specification | 2,100 | No | UDHAMPUR | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9718205.pdf
GEM_BID • 0.21 MB
qty150124_2026-08-06-14-06-22_b9a978e69d2f5adbb03e3fa553281549.pdf
BOQ • 0.33 MB
boq_item_sample_file-5_2026-08-06-14-06-22_5010c98f64796cf68cc16c13ac5e389e.csv
BOQ • 0.00 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].